Supernus Pharmaceuticals (SUPN) EPS (Diluted) Growth (3y) (2014 - 2025)
Supernus Pharmaceuticals (SUPN) EPS (Diluted) Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 50.12% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.26% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -70.43% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.24% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.96% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 64.19% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -18.62% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29.58% |
| Sep 30, 2025 | -200.38% |
| Jun 30, 2025 | 45.82% |
| Mar 31, 2025 | -35.85% |
| Dec 31, 2024 | 82.69% |
| Sep 30, 2024 | 20.14% |
| Jun 30, 2024 | -6.26% |
| Mar 31, 2024 | -70.97% |
| Dec 31, 2023 | -66.70% |
| Sep 30, 2023 | -33.76% |
| Mar 31, 2023 | -12.25% |
| Dec 31, 2022 | -12.42% |
| Sep 30, 2022 | -61.02% |
| Jun 30, 2022 | -40.46% |
| Mar 31, 2022 | 7.09% |
| Dec 31, 2021 | -54.55% |
| Sep 30, 2021 | -8.41% |
| Jun 30, 2021 | -8.56% |
| Mar 31, 2021 | -40.14% |
| Dec 31, 2020 | 30.77% |